Search

Your search keyword '"Castelnovo, Giovanni"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Castelnovo, Giovanni" Remove constraint Author: "Castelnovo, Giovanni" Database Academic Search Index Remove constraint Database: Academic Search Index
64 results on '"Castelnovo, Giovanni"'

Search Results

1. Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis.

2. Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis.

3. Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.

4. Unilateral subcortical extensive dilated perivascular spaces associated with superior sagittal sinus perivenous dilated spaces.

5. Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study.

6. Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France.

7. Cortical abnormalities on MRI: what a neurologist should know.

8. An MRI review of acquired corpus callosum lesions.

9. Thalamic Lesions: A Radiological Review.

10. Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria.

11. Brain MRI findings in long-standing and disabling multiple sclerosis in 84 patients

12. Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.

13. Camptocormia as presenting sign in myofibrillar myopathy

14. Quantification of Head Tremors in Medical Conditions: A Comparison of Analyses Using a 2D Video Camera and a 3D Wireless Inertial Motion Unit.

15. Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis.

16. Progressive ataxia related to PRRT2 gene mutation.

17. Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study.

19. Laryngospasm as preceding symptom of amyotrophic lateral sclerosis.

20. Characterization of novel CACNA1A splice variants by RNA‐sequencing in patients with episodic or congenital ataxia.

21. Night‐Time Apomorphine Infusion: Who Are the Best Candidates?

22. Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial.

23. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.

24. The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus.

25. Immune‐mediated diseases involving central and peripheral nervous systems.

27. Voluntary Ocular Flutter.

28. Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study.

29. Evaluation of CSF1R‐related adult onset leukoencephalopathy with axonal spheroids and pigmented glia diagnostic criteria.

30. Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study.

31. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.

32. The clinical meaning of levodopa equivalent daily dose in Parkinson's disease.

33. Comparison of SimoaTM and EllaTM to assess serum neurofilament‐light chain in multiple sclerosis.

34. Myocardial infarction after rituximab infusion.

35. Hemiballism due to an ipsilateral subthalamic nucleus lesion.

36. Abdominal Segmental Myoclonus Mimicking Belly Dancer Dyskinesias in CASPR2 Antibody Encephalomyelitis.

37. Rhythm disturbances as a potential early marker of Parkinson's disease in idiopathic REM sleep behavior disorder.

38. Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults.

39. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.

40. Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

42. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.

43. MRI volumetric morphometry in vascular parkinsonism.

44. A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies.

45. Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.

46. Beta-mannosidosis: A new cause of spinocerebellar ataxia

47. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.

48. Orthoptic and video-oculographic analyses in oculopharyngeal muscular dystrophy.

49. Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients.

50. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.

Catalog

Books, media, physical & digital resources